The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A pilot study of post-consolidation chemoimmunotherapy for high-risk neuroblastoma (ANBL19P1): A report from the Children’s Oncology Group.
 
Ami V. Desai
Stock and Other Ownership Interests - Pfizer; Viatris
Consulting or Advisory Role - GlaxoSmithKline; Recordati; Ymabs Therapeutics Inc
Research Funding - Actuate Therapeutics (Inst); GlaxoSmithKline (Inst); Jubilant DraxImage (Inst); Lilly (Inst); Merck (Inst); Roche (Inst); Ymabs Therapeutics Inc (Inst)
Travel, Accommodations, Expenses - Ymabs Therapeutics Inc
 
Arlene Naranjo
Consulting or Advisory Role - Novartis
 
Brian LaBarre
No Relationships to Disclose
 
Kelly C. Goldsmith
(OPTIONAL) Uncompensated Relationships - Abbvie/Genentech; Ymabs Therapeutics Inc
 
Meaghan P. Granger
No Relationships to Disclose
 
Lisa States
No Relationships to Disclose
 
Sean Green
No Relationships to Disclose
 
Mariel Trunzo
No Relationships to Disclose
 
Wendy Fitzgerald
No Relationships to Disclose
 
Steven G. DuBois
Consulting or Advisory Role - Amgen; Bayer; InhibRx; Jazz Pharmaceuticals
Research Funding - Bayer (Inst); BMS (Inst); Curis (Inst); Eisai (Inst); Lilly (Inst); Loxo (Inst); Merck (Inst); Pfizer (Inst); Roche/Genentech (Inst); Salarius Pharmaceuticals (Inst); Turning Point Therapeutics (Inst)
Travel, Accommodations, Expenses - Roche/Genentech; Salarius Pharmaceuticals
(OPTIONAL) Uncompensated Relationships - Ymabs Therapeutics Inc
 
Rochelle Bagatell
(OPTIONAL) Uncompensated Relationships - Bristol-Myers Squibb/Celgene
 
Julie R. Park
Patents, Royalties, Other Intellectual Property - Patent licensed to Umoja Pharmaceuticals, no monetary value to date
 
Araz Marachelian
Consulting or Advisory Role - US World; Ymabs Therapeutics Inc
Research Funding - Pfizer (Inst); United Therapeutics (Inst)